Market Cap 27.77M
Revenue (ttm) 0.00
Net Income (ttm) -41.84M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 27,000
Avg Vol 60,227
Day's Range N/A - N/A
Shares Out 3.52M
Stochastic %K 78%
Beta -2.34
Analysts Strong Sell
Price Target $99.78

Latest News on TPST

Tempest Therapeutics shares end wild week with 8% drop

Oct 13, 2023, 4:13 PM EDT - 1 year ago

Tempest Therapeutics shares end wild week with 8% drop


Top trending biotech stocks: ANVS, MTNB, AVTX, TPST

Oct 12, 2023, 11:26 AM EDT - 1 year ago

Top trending biotech stocks: ANVS, MTNB, AVTX, TPST

ANVS AVTX MTNB


Tempest Adopts Limited Duration Stockholder Rights Plan

Oct 11, 2023, 8:01 AM EDT - 1 year ago

Tempest Adopts Limited Duration Stockholder Rights Plan


Tempest to Present at the Jefferies Healthcare Conference

Jun 6, 2022, 4:05 PM EDT - 3 years ago

Tempest to Present at the Jefferies Healthcare Conference